Logo

HCTI

Healthcare Triangle, Inc.

HCTI

Healthcare Triangle, Inc. • NASDAQ
$2.24 ▼ -4.68% (-0.11)
Market Cap $13.16 M
52w High $435.75
52w Low $1.49
Dividend Yield 0%
P/E -0.04
Volume 69.65K
Outstanding Shares 5.87M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $3.489M ▼ $3.209M ▲ $-1.906M ▼ -54.629% ▼ $-89.92 ▼ $-1.811M ▼
Q2-2025 $3.558M ▼ $1.853M ▲ $-1.368M ▲ -38.449% ▲ $-64.54 ▲ $-1.347M ▼
Q1-2025 $3.704M ▲ $1.727M ▲ $-1.7M ▼ -45.896% ▲ $-80.2 ▼ $-1.275M ▼
Q4-2024 $2.19M ▼ $754K ▼ $-1.348M ▼ -61.553% ▼ $-59.23 ▼ $-636K ▲
Q3-2024 $2.413M $1.889M $-1.249M -51.761% $-54.89 $-824K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $1.629M ▼ $13.838M ▼ $5.112M ▲ $8.744M ▼
Q2-2025 $3.228M ▼ $14.568M ▲ $4.359M ▲ $10.209M ▲
Q1-2025 $6.826M ▲ $11.785M ▲ $3.208M ▼ $8.577M ▲
Q4-2024 $20K ▼ $1.961M ▼ $7.075M ▲ $-5.114M ▼
Q3-2024 $28K $4.766M $6.584M $-1.818M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-1.906M ▼ $-1.964M ▲ $-686K ▼ $1.051M ▲ $-1.599M ▲ $-2.65M ▲
Q2-2025 $-1.368M ▲ $-2.635M ▲ $-603K ▼ $-360K ▼ $-3.598M ▼ $-3.238M ▲
Q1-2025 $-1.7M ▼ $-5.557M ▼ $0 $12.363M ▲ $6.806M ▲ $-5.557M ▼
Q4-2024 $-1.348M ▼ $-811K ▼ $0 $803K ▲ $-8K ▼ $-811K ▼
Q3-2024 $-1.249M $715K $0 $-716K $-1K $715K

Revenue by Products

Product Q4-2022Q1-2023Q2-2023Q3-2023
Managed Services And Support
Managed Services And Support
 $0 ▲$0 ▲$0 ▲$0 ▲
Platform Services
Platform Services
 $0 ▲$0 ▲$0 ▲$0 ▲
Software Services
Software Services
 $10.00M ▲$10.00M ▲$10.00M ▲$0 ▼

Five-Year Company Overview

Income Statement

Income Statement The company operates at a very small revenue scale and has not yet achieved consistent profitability. Revenue has been modest and not clearly trending upward, while costs have kept results in the red most years. Gross profit is thin, and operating results hover around break-even to small losses, suggesting limited pricing power or scale so far. Persistent net losses show the business model is still in the build‑out or proving stage rather than a mature, profitable phase.

Balance Sheet

Balance Sheet The balance sheet is very light, with only a small base of assets and essentially no reported debt, which reduces financial leverage risk but also signals limited financial resources. Equity has recently slipped into negative territory, reflecting accumulated losses that now exceed the company’s book value. That combination—minimal assets, no meaningful cash cushion, and negative equity—points to financial fragility and a reliance on either improving operations or raising outside capital to support growth and ongoing activities.

Cash Flow

Cash Flow Cash generation has been weak and close to break-even, with occasional periods of cash burn. Operating cash flow has not consistently covered the needs of the business, and free cash flow has been slightly negative at times, indicating that even a lean investment program still strains internal resources. While capital spending appears very low, the lack of strong, positive cash flow leaves limited room to absorb shocks or fund expansion without external support.

Competitive Edge

Competitive Edge Healthcare Triangle operates in a specialized corner of healthcare IT, focusing on cloud, data, and AI solutions tailored to hospitals, life sciences companies, and other healthcare organizations. Its strength lies in deep healthcare domain expertise, regulatory know‑how, and a portfolio of proprietary platforms that can make it harder for clients to switch once systems are integrated. Partnerships with major cloud providers and leading electronic health record vendors add credibility and reach. On the other hand, the company is much smaller than many rivals, which can limit brand recognition, sales coverage, and resources to compete in large deals, making execution and focused positioning critical.

Innovation and R&D

Innovation and R&D Innovation is a clear bright spot. The company has built its own platforms for cloud enablement, data management, AI‑driven document processing, and generative AI infrastructure. These tools are tightly focused on healthcare needs such as interoperability, regulatory compliance, and turning unstructured medical data into usable information. The planned acquisition of an AI firm and a push toward subscription and SaaS models show an effort to move up the value chain and create recurring, higher‑margin revenue. The main risk is whether the company can commercialize these innovations at scale fast enough, given its limited financial cushion and the intense pace of AI competition.

Summary

Overall, Healthcare Triangle is an early‑stage, innovation‑driven healthcare IT player with interesting technology and a clearly defined niche, but operating on a very small financial base and with a track record of ongoing losses. Its strengths are in specialized healthcare expertise, proprietary platforms, strong compliance focus, and strategic partnerships, all of which could support a more durable business if adoption grows. Key uncertainties center on its ability to stabilize and grow revenue, turn innovation into scalable recurring income, and strengthen its balance sheet and cash flow before financial constraints become more pressing. The story is less about current financial strength and more about whether the company can successfully execute its strategic and AI‑driven growth plans in time.

NEWS

November 24, 2025 · 4:11 PM UTC

Spartan Capital Securities, LLC Serves as Sales Agent in Healthcare Triangle, Inc.'s $20 Million At-the-Market Offering

Read more

October 14, 2025 · 8:15 AM UTC

Healthcare Triangle's Strategic Intent Rewarded with a 32% Share Gain Since September (NASDAQ:HCTI)

Read more

October 13, 2025 · 3:00 PM UTC

Healthcare Triangle Plays Offense to Redefine What Aggressive Growth Looks Like (NASDAQ: HCTI)

Read more

October 10, 2025 · 10:25 AM UTC

Healthcare Triangle Executes Aggressive Growth Strategy, Announcing Within One Week Both $34 Million Planned Acquisition Revenue and Processing of $20 Million in Revenue Generated by Healthcare Providers on Ezovion Platform

Read more

October 10, 2025 · 9:15 AM UTC

Healthcare Triangle, a $16M Microcap, Targets Teyame.AI and Its $34M FY2025 (NASDAQ: HCTI)

Read more